{"id":"W4408080074","doi":"10.1016/j.breast.2025.104432","title":"A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Association of Schools and Colleges of Optometry; Breakthrough Cancer Research; Translational Breast Cancer Research Consortium; Susan G. Komen; AbbVie; Breast Cancer Research Foundation; National Cancer Institute; Conquer Cancer Foundation; Sidney Kimmel Comprehensive Cancer Center; Genentech; Susan G. Komen for the Cure","keywords":"Medicine; Pertuzumab; Trastuzumab; Breast cancer; Oncology; Biomarker; Internal medicine; Neoadjuvant therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001385407,0.0005954817,0.0005763439,0.0006212095,0.0001912321,0.000707313,0.0005492318,0.0004744529,0.0008100244],"category_scores_gemma":[0.002752217,0.0002030282,0.0004470143,0.0005147814,0.0002239687,0.0002530548,0.0004355569,0.0005664326,0.0003908676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000504399,"about_ca_system_score_gemma":0.0003636123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001595257,"about_ca_topic_score_gemma":0.002766668,"domain_scores_codex":[0.9996853,0.00008709029,0.00003116,0.00007233581,0.00008610127,0.00003815896],"domain_scores_gemma":[0.9989879,0.0002446401,0.0002960413,0.00005619182,0.0001688521,0.0002463231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002907478,0.0001496775,0.9828765,0.00002577772,0.00009561332,0.0001354859,0.00003240768,0.001191804,0.003532773,0.00001495086,0.0002192705,0.008818289],"study_design_scores_gemma":[0.0002752634,0.002444466,0.9658925,0.00001740568,0.0001688147,0.001953954,0.00009559713,0.02323737,0.005160667,0.00008936571,0.0006435884,0.00002120461],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991091,0.0001792908,0.000267172,0.00004912346,0.000003817042,0.00001664173,0.0001960041,0.00000970901,0.0001691318],"genre_scores_gemma":[0.998483,0.00004005926,0.0007025495,0.00002277092,0.000007115037,0.00001711392,0.0005988192,0.000002845061,0.0001256878],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001595257,"threshold_uncertainty_score":0.007326841,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01518711006540524,"score_gpt":0.3401464071977882,"score_spread":0.3249592971323829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}